Deferoxamine
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-B1625-1MG | 1 mg | 124,00 | Add | |
| HY-B1625-5MG | 5 mg | 292,00 | Add | |
| HY-B1625-1ML | 10mM/1mL | 355,00 | Add | |
| HY-B1625-10MG | 10 mg | 459,00 | Add | |
| HY-B1625-25MG | 25 mg | 614,00 | Add | |
| HY-B1625-50MG | 50 mg | 898,00 | Add | |
| HY-B1625-100MG | 100 mg | 1'285,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Deferoxamine B; Deferriferrioxamine B; Deferrioxamine
Deferoxamine (Deferoxamine B) is an iron chelator (binds to Fe (III) and many other metal cations) , is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine upregulates HIF-1α levels with good antioxidant activity. Deferoxamine also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and anti-COVID-19[1][2][3][4][5].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Infection, Metabolic Disease, Inflammation/Immunology, Neurological Disease |
| Format | Solubility: DMSO : 10 mg/mL (ultrasonic;warming;heat to 60°C) ;H2O : < 0.1 mg/mL (ultrasonic) |
| Grade | Clinical information: Launched |
| Purity | 99.76% |
| Molecular Formula | C25H48N6O8 |
| Molecular Weight | 560.68 |
| CAS-Number | 70-51-9 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |